If FDA are thinking big picture, stemcell industry wide, might they also build their own bridge so to speak, by commissioning an independent medical research institution to investigate methods of proving potency batch to batch. On the run so to speak and apply any method found to remestemcel-L retrospectively?
- Forums
- ASX - By Stock
- MSB
- FDA ODAC Meeting Material discussion analysis
FDA ODAC Meeting Material discussion analysis, page-344
-
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.18 |
Change
0.018(1.50%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.417M | 1.210M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 16396 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 37901 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 2121 | 1.175 |
17 | 124835 | 1.170 |
12 | 120177 | 1.165 |
14 | 170586 | 1.160 |
10 | 470765 | 1.155 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 62054 | 9 |
1.185 | 49927 | 9 |
1.190 | 145600 | 13 |
1.195 | 104633 | 12 |
1.200 | 93817 | 15 |
Last trade - 11.15am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online